Clinical Trial Update: The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO): Open Trial [Phase 2]

View source ↗

Summary

Phase 2 open trial SYNCHRO evaluating Omega-3 polyunsaturated fatty acids for depressive symptoms in pregnant individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Omega-3 PUFAs (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: Tokyo Medical University | Conditions: Pregnancy, Depression | Phase 2 | Status: COMPLETED